Portside Wealth Group LLC Sells 156 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Portside Wealth Group LLC trimmed its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 1.6% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,533 shares of the medical device company’s stock after selling 156 shares during the period. Portside Wealth Group LLC’s holdings in Cooper Companies were worth $832,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of COO. Vanguard Group Inc. grew its holdings in Cooper Companies by 303.0% during the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after purchasing an additional 17,367,502 shares during the last quarter. Capital World Investors grew its stake in Cooper Companies by 301.7% in the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock valued at $573,657,000 after buying an additional 4,246,519 shares during the last quarter. Janus Henderson Group PLC raised its holdings in Cooper Companies by 279.8% in the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after acquiring an additional 2,532,186 shares during the period. Bessemer Group Inc. lifted its position in Cooper Companies by 305.2% during the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock worth $203,013,000 after acquiring an additional 1,507,049 shares during the last quarter. Finally, Champlain Investment Partners LLC boosted its holdings in Cooper Companies by 295.3% during the first quarter. Champlain Investment Partners LLC now owns 1,741,120 shares of the medical device company’s stock valued at $176,654,000 after acquiring an additional 1,300,620 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the subject of a number of research analyst reports. Robert W. Baird upped their price target on Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a report on Friday, May 31st. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, May 31st. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $115.00 target price on shares of Cooper Companies in a research note on Wednesday, July 3rd. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $111.78.

Cooper Companies Price Performance

Shares of NASDAQ COO traded up $2.14 during trading on Friday, reaching $94.14. The company had a trading volume of 785,196 shares, compared to its average volume of 1,105,073. The Cooper Companies, Inc. has a 52 week low of $75.93 and a 52 week high of $104.07. The business’s 50 day moving average price is $90.77 and its 200-day moving average price is $93.99. The stock has a market cap of $18.75 billion, a PE ratio of 55.38, a PEG ratio of 2.34 and a beta of 0.98. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The company had revenue of $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. During the same quarter in the previous year, the company posted $0.77 earnings per share. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. Analysts expect that The Cooper Companies, Inc. will post 3.57 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.